PSMA–DA1
2703051-77-6
|
PSMA-ALB-56
2306049-48-7
|
PSMA; peptide 288-297
345634-90-4
|
PSMA-ligand-1
1610413-97-2
|
PSMA I&T
2192281-54-0
|
PSMA I&S
2639475-07-1
|
PSMA-617
1702967-37-0
|
Osimertinib analogue
2050521-74-7
|
EZETIMIBE ANALOGUE
194423-53-5
|
Benzamide, N-[1-[[[4-[[2,5-dioxo-1-[4-(2-phenyldiazenyl)phenyl]-3-pyrrolidinyl]thio]phenyl]amino]carbonyl]-2-[4-(phenylmethoxy)phenyl]ethenyl]-
901989-63-7
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
(E)-3-(furan-2-yl)-N-(2-(2-(pyrimidin-2-yl)-1H-imidazol-1-yl)ethyl)acrylamide
1798403-43-6
|
3-(Isobutylsulfonyl)-1-((4-(trifluoromethyl)benzyl)sulfonyl)azetidine
1796970-48-3
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
